A comprehensive study, integrating TCGA datasets, clinical samples, and both in vivo and in vitro experiments, suggests that ACOX2 impedes the progression of liver cancer through the PPARα pathway (Zhang et al. 2021). The gene discussed is PPARA; the disease is liver cancer.